Figure 1

Statistical and fold change evaluation between the study groups control (Ctrl), chronic kidney disease (CKD), end stage renal disease (ESRD)). (A) Venn diagram showing One-way ANOVA between the study groups using Tueky’s Post-hoc analysis FDR P < 0.05. (B) 101 metabolic features were dysregulated significantly between the study groups.